Seizures on Wellbutrin (bupropion) are uncommon. At standard doses, roughly 1 in 250 to 1 in 1,000 people experience a seizure, depending on the dose. That translates to an incidence of about 0.1% at doses below 300 mg per day and 0.4% at doses up to 450 mg per day. While the risk is low in absolute terms, it’s higher than most other antidepressants, which is why seizures are one of the most talked-about side effects of this medication.
How Dose Affects Seizure Risk
Seizure risk with Wellbutrin is directly tied to how much you take. At daily doses under 300 mg, the risk sits around 0.1%. At doses up to 450 mg per day, the FDA’s maximum, that risk climbs to about 0.4%. A large prospective study involving 102 medical centers found a seizure rate of 0.36% among patients taking between 300 and 450 mg daily over eight weeks.
The jump in risk above 450 mg per day is steep enough that the FDA sets a hard ceiling there. For the original immediate-release formulation, the maximum single dose is also capped at 150 mg to prevent a sudden spike in blood levels. Going above the recommended dose, whether intentionally or by accident, changes the math considerably. In overdose situations, seizures occur in roughly one-third of cases.
Why Wellbutrin Lowers the Seizure Threshold
The exact mechanism behind bupropion-related seizures isn’t fully understood. What researchers do know is that the drug increases levels of dopamine and norepinephrine in the brain, and this stimulating activity can make nerve cells more excitable. That heightened excitability is what “lowering the seizure threshold” means in practice: it takes less provocation for the brain to fire off the synchronized electrical activity that produces a seizure. The extended-release (XL) and sustained-release (SR) formulations were designed in part to smooth out the peaks in blood concentration that the original immediate-release version produced, since those peaks are thought to contribute to seizure risk.
Who Faces Higher Risk
The 0.1% to 0.4% figures apply to the general population taking Wellbutrin at recommended doses. Certain conditions push the risk higher, sometimes dramatically.
The FDA specifically contraindicates Wellbutrin in people with:
- A seizure disorder (epilepsy or any history of seizures)
- Bulimia or anorexia nervosa, current or past, because clinical trials showed a notably higher seizure rate in these patients
- Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or anti-seizure medications, all of which can trigger seizures on their own and compound the risk when combined with bupropion
- Severe head injury, brain tumors, or prior stroke
Beyond those hard contraindications, several other factors can tip the balance. Heavy alcohol use is one of the most significant. Animal research has shown that alcohol and bupropion together lower the seizure threshold far more than either substance alone. Cocaine and other stimulants carry a similar compounding risk. Metabolic problems like low blood sugar or low sodium levels also increase vulnerability, as does severe liver impairment. If you have moderate to severe liver disease, the recommended maximum dose drops to just 75 mg per day.
Other medications matter too. Taking Wellbutrin alongside antipsychotics, older tricyclic antidepressants, theophylline (used for asthma), or systemic steroids can further lower the seizure threshold. Even other bupropion products count. If you’re using a bupropion-based smoking cessation aid and a bupropion antidepressant simultaneously, the combined dose increases your risk.
XL vs. SR vs. Immediate Release
Wellbutrin comes in three formulations, and they handle the drug differently in your body. The original immediate-release (IR) version produces a sharp spike in blood levels after each dose, which is why it’s taken three times a day in smaller amounts. The sustained-release (SR) version, taken twice daily, and the extended-release (XL) version, taken once daily, both deliver the drug more gradually.
The SR and XL formulations maintain more stable blood concentrations throughout the day. This smoother delivery is generally better tolerated and is thought to reduce peak-related side effects. However, the overall seizure incidence at equivalent daily doses remains similar across formulations. The key factor is total daily dose, not which version you take. For the XL formulation specifically, the seizure risk increases notably above 400 mg per day.
How to Minimize Your Risk
The most protective step is staying within recommended doses. The FDA advises gradual dose increases rather than jumping straight to a higher amount. A typical starting approach involves beginning at a lower dose and working up over several days, giving your body time to adjust to each level. This slow titration helps avoid the sudden blood-level spikes most closely linked to seizures.
If you drink alcohol, the interaction with Wellbutrin deserves serious attention. Combining the two raises seizure risk, and so does abruptly quitting alcohol after heavy or prolonged use. Keeping your prescribing provider informed about your alcohol use, any history of seizures (even febrile seizures in childhood), and every other medication or supplement you take gives them the information needed to judge whether bupropion is a safe choice for you and at what dose.
For the vast majority of people taking Wellbutrin as prescribed and without the risk factors listed above, the chance of a seizure is well under 1%. It’s a real risk, not a theoretical one, but it’s uncommon enough that millions of people take bupropion safely every year for depression, seasonal mood disorders, and smoking cessation.